Your browser doesn't support javascript.
loading
Effects of adiponectin, plasma D-dimer, inflammation and tumor markers on clinical characteristics and prognosis of patients with ovarian cancer.
Li, Hui; Sun, Lulu; Chen, Lili; Kang, Zhihui; Hao, Guorong; Bai, Fenglou.
Afiliación
  • Li H; The Fourth Hospital of Shijiazhuang (Obstetrics and Gynaecology Hospital), Department of Gynecology, Shijiazhuang City, Hebei Province, China.
  • Sun L; The Fourth Hospital of Shijiazhuang (Obstetrics and Gynaecology Hospital), Department of Obstetrics, Shijiazhuang City, Hebei Province, China.
  • Chen L; The Fourth Hospital of Shijiazhuang (Obstetrics and Gynaecology Hospital), Department of Gynecology, Shijiazhuang City, Hebei Province, China.
  • Kang Z; The Fourth Hospital of Shijiazhuang (Obstetrics and Gynaecology Hospital), Department of Obstetrics, Shijiazhuang City, Hebei Province, China.
  • Hao G; The Fourth Hospital of Shijiazhuang (Obstetrics and Gynaecology Hospital), Department of Gynecology, Shijiazhuang City, Hebei Province, China.
  • Bai F; The Fourth Hospital of Shijiazhuang (Obstetrics and Gynaecology Hospital), Department of Gynecology, Shijiazhuang City, Hebei Province, China.
J Med Biochem ; 41(1): 71-78, 2022 Feb 02.
Article en En | MEDLINE | ID: mdl-35431651
ABSTRACT

Background:

To investigate the effects of adiponectin (ADPN), plasma D-dimer (D-D), inflammation, and tumour markers on clinical characteristics and prognosis of patients with ovarian cancer.

Methods:

A total of 80 patients with ovarian cancer treated in our hospital from April 2017 to November 2019 were enrolled as study subjects and evenly divided into an observation group (patients with ovarian cancer) and a control group (patients with the benign ovarian tumour) based on the results of the postoperative pathological biopsy. The levels of ADPN, plasma D-D, inflammatory factors, and serum tumour markers carbohydrate antigen 125 (CA125), human epididymis protein 4 (HE4), and risk of ovarian malignancy algorithm (ROMA) were compared between the two groups. The diagnostic value of serum tumour markers CA125, HE4, and ROMA in ovarian cancer was explored. The correlations of ROMA changes with the changes in the levels of ADPN, plasma D-D, high-sensitivity C-reactive protein (hs-CRP), CA125, and HE4 were analysed. Additionally, the related risk factors affecting the development of ovarian cancer were subjected to univariate and multivariate logistic regression analyses.

Results:

In comparison with the control group, the observation group exhibited a lowered ADPN level (p<0.05), notably raised levels of plasma D-D, inflammatory factors hs-CRP and interleukin-6 (IL-6) and serum tumour markers CA125 and HE4 and an evidently increased ROMA (p<0.05). Besides, the detection of serum ROMA showed the highest specificity and sensitivity and low false-positive rate and false-negative rate. The changes of ROMA were positively correlated with the changes in the levels of plasma D-D, hs-CRP, CA125, and HE4 (p<0.05) and negatively associated with the changes in ADPN level (p<0.05). The results of the univariate analysis showed that abnormal ADPN, D-D, hs-CRP, IL-6, CA125, and HE4 levels were related to risk factors affecting the development of ovarian cancer. It was found through multivariate logistic regression analysis that decreased ADPN level and increased D-D, hsCRP, IL-6, CA125, and HE4 levels were independent risk factors affecting the development of ovarian cancer.

Conclusions:

In the case of ovarian cancer, the ADPN level declines, while the levels of plasma D-D, inflammatory factors, and serum tumour markers CA125, HE4, and ROMA rise obviously. Besides, the ROMA level displays a positive relation to the content of CA125, HE4, plasma D-D, and inflammatory factors and a negative association with the ADPN level.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: J Med Biochem Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: J Med Biochem Año: 2022 Tipo del documento: Article País de afiliación: China